CASP3 and infection: Compared to untreated cells, cells pre-treated with Casp3 inhibitor showed significant reduction in the secretion of IL-1β in WT BMDM, however there was no significant difference in IL-1β release in GsdmD-/- BMDM during ΔpknF mutant infection (S8B Fig).